Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calcium signaling and polycystin-2.

Georgia I Anyatonwu1, Barbara E Ehrlich

  • 1Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA.

Biochemical and Biophysical Research Communications
|September 1, 2004
PubMed
Summary

Polycystic kidney disease (PKD) stems from mutations in PKD1 and PKD2 genes. Understanding the polycystin-1/polycystin-2 protein signaling pathway is key to uncovering cyst formation mechanisms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood-based proteomic profiling reveals context-dependent changes in BCL2-associated signaling during taxane therapy in breast cancer patients.

FEBS open bio·2026
Same author

Pathological Calcium Signaling in Traumatic Brain Injury and Alzheimer's Disease: From Acute Neuronal Injury to Chronic Neurodegeneration.

International journal of molecular sciences·2025
Same author

Calpain in Traumatic Brain Injury: From Cinderella to Central Player.

Cells·2025
Same author

Monomethyl auristatin E and paclitaxel use different mechanisms to alter intracellular calcium signaling.

Biochemical pharmacology·2025
Same author

Chemotherapy-induced neuropathy in monomethyl Auristatin E treatment: prevention by lithium.

British journal of cancer·2025
Same author

Adaptation to Volumetric Compression Drives an Apoptosis-Resistant and Invasive Phenotype in Liver Cancer.

Cancer research·2025

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • Polycystic kidney disease (PKD) is a genetic disorder caused by mutations in the PKD1 and PKD2 genes.
  • These genes encode polycystin-1 (PC1) and polycystin-2 (PC2) proteins, respectively, crucial for kidney function.
  • The precise molecular events linking these mutations to clinical symptoms remain largely unknown.

Purpose of the Study:

  • To elucidate the molecular signaling pathway involving PC1 and PC2 proteins in normal kidney function.
  • To investigate the functional consequences of PC1/PC2 mutations in the context of PKD.
  • To determine the role of calcium (Ca2+) signaling in the pathogenesis of PKD cystogenesis.

Main Methods:

  • Investigating the localization and function of PC1 and PC2 proteins in primary cilia.
  • Analyzing the role of PC1/PC2 as a mechanosensitive receptor complex for calcium (Ca2+) entry.
  • Examining downstream signaling events, including the activation of ryanodine receptors (RyRs).

Main Results:

  • PC1 and PC2 proteins form a complex in primary cilia, acting as a mechanosensitive calcium (Ca2+) channel.
  • Activation of intracellular Ca2+ release channels, such as RyR, is involved in the downstream signaling pathway.
  • The exact sequence of molecular events following PC1/PC2 dysfunction and Ca2+ dysregulation in cystogenesis is still under investigation.

Conclusions:

  • Understanding the normal function of the PC1/PC2 complex and the impact of mutations is critical for deciphering PKD.
  • Calcium (Ca2+) signaling plays a significant role in the molecular mechanisms underlying PKD.
  • Further research into these pathways will illuminate the process of cystogenesis and inform potential therapeutic strategies.

Related Experiment Videos